Presumed Influence of Direct-to-Consumer (DTC) Prescription Drug Advertising on Patients: The Physician's Perspective

References

• Advertising Age (2005), "Fiftieth Annual 100 Leading National Advertisers" (June 27), available at www.adage.com/images/random/lna2005.pdf
   Google Scholar
• Allison-Ottey, Sharon D., Karen Ruffin, and Kimberly B. Allison (2002), "To Do No Harm' Survey of NMA Physicians Regarding Perceptions on DTC Advertisements," National Journal of the Medical Association, 94 (4), 194-202.
   Google Scholar
• American Academy of Pediatrics 2003), "Pediatricians' Attitudes Towards and Experiences with Direct-to-Consumer Advertising (DTCA) of Prescription Drugs: A National Survey" (abstract), available at www.aap.org/research/periodicsurvey/ps52acadhlth03.htm
   Google Scholar
• American Medical Association (AMA) (2003), "H-105.988 Direct-to-Consumer Advertising (DTCA) of Prescription Drugs," available at www.ama-assn.org/apps/pf_online?f_n=browse&doc=policyfiles/HnE/H-105.988.HTM
   Google Scholar
• Armstrong, J. Scott, and Terry S. Overton (1977), "Estimating Nonresponse Bias in Mail Surveys," Journal of Marketing Research, 14 (3), 396-402.
   Google Scholar
• Arnould, Eric, Linda Price, and George M. Zinkhan (2002), Consumers, New York: McGraw-Hill.
   Google Scholar
• Bédard, Jean, and Micheline T. H. Chi (1992), "Expertise," Current Directions in Psychological Science, 1 (4), 135-139.
   Google Scholar
• Borzekowski, Dina L. G., and Albert C. Gunther (2004), "The Presumed Influence Model: Linking Social and Media [Mis]perceptions with Youth Smoking Susceptibility," Journal of Adolescent Health, 34 (2), 153.
   Google Scholar
• Brosius, Hans-Bernd, and Dirk Engel (1996), "The Causes of Third-Person Effects: Unrealistic Optimism, Impersonal Impact, or Generalized Negative Attitudes Towards Media Influence?" International Journal of Public Opinion Research, 8 (2), 142-162.
   Google Scholar
• Calfee, John E. (2002), "Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs," Journal of Public Policy and Marketing, 21 (2), 174-193.
   Google Scholar
• Chapin, John R. (1999), "Third-Person Perception and Sexual Risk Taking Among Minority ‘At-Risk’ Youth," Mass Communication and Society, 2 (3/4), 163-173.
   Google Scholar
• Cutrer, Christine M., and Andreas M. Pleil (1991), "Potential Outcomes Associated with Direct-to-Consumer Advertising of Prescription Drugs: Physicians' Perspectives," Journal of Pharmaceutical Marketing and Management, 5 (3), 3-19.
   Google Scholar
• Davison, W. Phillips (1983), "The Third-Person Effect in Communication," Public Opinion Quarterly, 47 (1), 1-15.
   Google Scholar
• DeLorme, Denise, Jisu Huh, and Leonard N. Reid (2006), "Perceived Effects of DTC Prescription Drug Advertising on Self and Others: A Third-Person Effect Study of Older Consumers," Journal of Advertising, 35 (3), 49-68.
   Google Scholar
• Drug Industry Daily (2005), "Industry Warns FDA Not to Prohibit DTC; Agency Considering New Rules" (November 2), LexisNexis Academic database (accessed January 5, 2006).
   Google Scholar
• Duck, Julie M., and Barbara-Ann Mullin (1995), "The Perceived Impact of the Mass Media: Reconsidering the Third Person Effect," European Journal of Social Psychology, 25 (1), 77-93.
   Google Scholar
• Duck, Julie M., Deborah J. Terry, and Michael A. Hogg (1995), "The Perceived Influence of AIDS Advertising: The Third-Person Effect in the Context of Positive Media Content," Basic and Applied Social Psychology, 17 (3), 117-140.
   Google Scholar
• Ericsson, K. Anders (2005), "Recent Advances in Expertise Research: A Commentary on the Contributions to the Special Issue," Applied Cognitive Psychology, 19 (2), 233-241.
   Google Scholar
• Findlay, Steven D. (2001), "Direct-to-Consumer Promotion of Prescription Drugs: Economic Implications for Patients, Payers and Providers," Pharmacoeconomics, 19 (2), 109-119.
   Google Scholar
• Fishbein, Martin (1980), "A Theory of Reasoned Action: Some Applications and Implications," in Nebraska Symposium on Motivation, vol. 27, Herbert E. Howe and Monte M. Page, eds., Lincoln: University of Nebraska Press, 65-116.
   Google Scholar
• Gonul, Fusun F., Franklin Carter, and Jerry Wind (2000), "What Kind of Patients and Physicians Value Direct-to-Consumer Advertising of Prescription Drugs," Health Care Management Science, 3 (3), 215-226.
   Google Scholar
• Gunther, Albert (1991), "What We Think Others Think," Communication Research, 18 (3), 355-372.
   Google Scholar
• Gunther, Albert, and J. Douglas Storey (2003), "The Influence of Presumed Influence," Journal of Communication, 53 (2), 199-215.
   Google Scholar
• Gunther, Albert, and Esther Thorson (1992), "Perceived Persuasive Effects of Product Commercials and Public Service Announcements: Third-Person Effects in New Domains," Communication Research, 19 (5), 574-596.
   Google Scholar
• Hair, Joseph F., Rolph E. Anderson, Ronald L. Tatham, and William C. Black (1998), Multivariate Data Analysis, 5th ed., Upper Saddle River, NJ: Prentice Hall.
   Google Scholar
• Heider, Fritz (1958), The Psychology of Interpersonal Relations, New York: John Wiley.
   Google Scholar
• Hense, Richard, and Christian Wright (1992), "The Development of the Attitudes Toward Censorship Questionnaire," Journal of Applied Social Psychology, 22 (21), 1666-1675.
   Google Scholar
• Hoffner, Cynthia, and Martha Buchanan (2002), "Parents' Responses to Television Violence: The Third-Person Perception, Parental Mediation, and Support for Censorship," Media Psychology, 4 (3), 231-252.
   Google Scholar
• Hollon, Matthew F. (1999), "Direct-to-Consumer Marketing of Prescription Drugs: Creating Consumer Demand," Journal of the American Medical Association, 281 (4), 382-384.
   Google Scholar
• Huh, Jisu, Denise DeLorme, and Leonard N. Reid (2004), "The Third-Person Effect and Its Influence on Behavioral Outcomes in a Product Advertising Context: The Case of Direct-to-Consumer Prescription Drug Advertising," Communication Research, 31 (5), 568-599.
   Google Scholar
• IMS Health (1998), "Majority of Physicians Have Negative View Towards DTC Advertising," press release (September 15).
   Google Scholar
• IMS Health (2004), "Total U.S. Promotional Spend by Type, 2003," available at www.imshealth.com/ims/portal/front/articleC/0,2777,6599_44304752_44304752_448890,0.html
   Google Scholar
• Jensen, Jakob D., and Ryan J. Hurley (2005), "Third-Person Effects and the Environment: Social Distance, Social Desirability, and Presumed Behavior," Journal of Communication, 55 (2), 242-256.
   Google Scholar
• Jones, Edward E., and Keith E. Davis (1965), "From Act to Dispositions: The Attribution Process in Person Perception," in Advances in Experimental Social Psychology, vol. 2, Leonard Berkowitz, ed., New York: Academic Press, 219-266.
   Google Scholar
• Kelley, Harold H. (1972), "Attribution in Social Interaction," in Attribution: Perceiving the Causes of Behavior, Edward E. Jones, David E. Kanouse, Harold H. Kelley, Richard E. Nisbett, Stuart Valins, and Bernard Weiner, eds., Morristown, NJ: General Learning Press, 1-26.
   Google Scholar
• Kravitz, Richard L., Ronald M. Epstein, Mitchell D. Feldman, Carol E. Franz, Rahman Azari, Michael S. Wilkes, Ladson Hinton, and Peter Franks (2005), "Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial," JAMA, 293 (16), 1995-2002.
   Google Scholar
• Lexchin, Joel, and Barbara Mintzes (2002), "Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No," Journal of Public Policy and Marketing, 21 (2), 194-201.
   Google Scholar
• Lipsky, Martin S., and Christine A. Taylor (1997), "The Opinions and Experiences of Family Physicians Regarding Direct-to-Consumer Advertising," Journal of Family Practice, 45 (6), 495-499.
   Google Scholar
• MacKenzie, Scott B., and Richard J. Lutz (1989), "An Empirical Examination of the Antecedents of Attitude Toward the Ad in an Advertising Pretesting Context," Journal of Marketing, 53 (2), 48-65.
   Google Scholar
• McClosky, Herbert, and Alida Brill (1983), Dimensions of Tolerance: What Americans Believe About Civil Liberties, New York: Russell Sage Foundation.
   Google Scholar
• Meirick, Patrick C. (2004), "Topic-Relevant Reference Groups and Dimensions of Distance," Communication Research, 31 (2), 234-255.
   Google Scholar
• Mintzes, Barbara (2001), An Assessment of the Health System Impacts of Direct-to-Consumer Advertising of Prescription Medicines (DTCA), vol. 2: Literature Review: Direct-to-Consumer Advertising of Prescription Drugs: What Do We Know Thus Far About Its Effects on Health and Health Care Services? (August), University of British Columbia: UBC Centre for Health Services and Policy Research.
   Google Scholar
• Mintzes, Barbara, Morris L. Barer, Richard L. Kravitz, Ken Bassett, Joel Lexchin, Arminée Kazanjian, Robert G. Evans, Richard Pan, and Stephan A. Marion (2003), "How Does Direct-to-Consumer Advertising (DTCA) Affect Prescribing? A Survey in Primary Care Environments With and Without Legal DTCA," Canadian Medical Association Journal, 169 (5), 405-412.
   Google Scholar
• Muehling, Darrel D. (1987), "An Investigation of Factors Underlying Attitude-Toward-Advertising-in-General," Journal of Advertising, 16 (1), 32-40.
   Google Scholar
• Murray, Elizabeth, Bernard Lo, Lance Pollack, Karen Donelan, and Ken Lee (2003), "Direct-to-Consumer Advertising: Physicians' Views of Its Effects on Quality of Care and the Doctor—Patient Relationship," Journal of the American Board of Family Practice, 16 (6), 513-524.
   Google Scholar
• Mutz, Diana C. (1989), "The Influence of Perceptions of Media Influence: Third Person Effects and the Public Expression of Opinions," International Journal of Public Opinion Research, 1 (1), 3-23.
   Google Scholar
• Nadal, Caroline L. (2001), "Notes and Comments: The Societal Value of Prescription Drug Advertisements in the New Millennium: Targeted Consumers Become the Learned," Journal of Law and Policy, 451, LexisNexis Academic database (accessed December 2, 2002).
   Google Scholar
• National Health Council (2002), "Direct-to-Consumer Prescription Drug Advertising: Overview and Recommendations" (January), available at www.nationalhealthcouncil.org/advocacy/DTC_paper.pdf
   Google Scholar
• Ostrove, Nancy (2001), Statement of Nancy Ostrove, Ph.D., Deputy Director of the Division of Drug Marketing, Advertising and Communications of the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Department of Health and Human Services, Before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism, Senate Committee on Commerce, Science, and Transportation (July 24), available at www.fda.gov/ola/2001/drugprom00724.html
   Google Scholar
• Park, Sung-Yeon (2005), "The Influence of Presumed Media Influence on Women's Desire to Be Thin," Communication Research, 32 (5), 594-614.
   Google Scholar
• Patel, Vimla L., Robert Glaser, and Jose F. Arocha (2000), "Cognition and Expertise: Acquisition of Medical Competence," Clinical and Investigative Medicine, 23 (4), 256-260.
   Google Scholar
• Paul, David P., Amy Handlin, and Angela D'Auria Stanton (2002), "Primary Care Physicians' Attitudes Toward Direct-to-Consumer Advertising of Prescription Drugs: Still Crazy After All These Years," Journal of Consumer Marketing, 19 (7), 564-574.
   Google Scholar
• Perloff, Richard M. (1989), "Ego-Involvement and the Third Person Effect of Televised News Coverage," Communication Research, 16 (2), 236-262.
   Google Scholar
• Petroshius, Susan M., Philip A. Titus, and Kathryn J. Hatch (1995), "Physician Attitudes Toward Pharmaceutical Drug Advertising," Journal of Advertising Research, 35 (6), 41-51.
   Google Scholar
• Pines, Wayne L. (1999), "A History and Perspective on Direct-to-Consumer Promotion," Food and Drug Law Journal, 54 (4), 489-518.
   Google Scholar
• Pollay, Richard W., and Banwari Mittal (1993), "Here's the Beef: Factors, Determinants, and Segments in Consumer Criticism of Advertising," Journal of Marketing, 57 (3), 99-114.
   Google Scholar
• Prevention and APA (American Pharmaceutical Association) (1999), National Survey of Consumer Reactions to Direct-to-Consumer Advertising (July).
   Google Scholar
• Prevention and APA (American Pharmaceutical Association) (2001), Fifth Annual Survey: Consumer Reactions to DTC Advertising of Prescription Medicines, 2001-2002.
   Google Scholar
• Reardon, Thomas (1999), "Direct-to-Consumer Advertisements of Prescription Drugs: The Physician Perspective," in IBC's 1999 Inaugural DTC Marketing Congress, Southborough, MA: IBC.
   Google Scholar
• Robinson, Andrew R., Kirsten B. Hohmann, Julie I. Rifkin, Daniel Topp, Christine M. Gilroy, Jeffrey A. Pickard, and Robert J. Anderson (2004), "Direct-to-Consumer Pharmaceutical Advertising: Physician and Public Opinion and Potential Effects on the Physician—Patient Relationship," Archives of Internal Medicine, 164 (4), 427-432.
   Google Scholar
• Rosenthal, Meredith B., Ernst R. Berndt, Julie M. Donohue, Richard G. Frank, and Arnold M. Epstein (2002), "Promotion of Prescription Drugs to Consumers," New England Journal of Medicine, 346 (7), 498-505.
   Google Scholar
• Rucinski, Dianne, and Charles T. Salmon (1990), "The ‘Other’ as the Vulnerable Voter: A Study of the Third-Person Effect in the 1988 U.S. Presidential Campaign," International Journal of Public Opinion Research, 2 (4), 345-368.
   Google Scholar
• Salwen, Michael B. (1998), "Perception of Media Influence and Support for Censorship," Communication Research, 25 (3), 259-285.
   Google Scholar
• Salwen, Michael B., and Michel Dupagne (1999), "The Third-Person Effect," Communication Research, 26 (5), 523-549.
   Google Scholar
• Stavchansky, Liza E. (2000), "An Exploratory Study of Consumer, Community Pharmacist, and Physician Attitudes and Comprehension of Direct-to-Consumer Prescription Drug Advertising," unpublished doctoral dissertation, University of Texas at Austin.
   Google Scholar
• Sternthal, Brian, and C. Samuel Craig (1982), Consumer Behavior: An Information Processing Perspective, Englewood Cliffs, NJ: Prentice Hall.
   Google Scholar
• Thomaselli, Rich (2005), "Don't Count Out DTC Marketers," Advertising Age (June 27), S-16.
   Google Scholar
• Tsfati, Yariv, and Jonathan Cohen (2005), "The Influence of Presumed Media Influence on Democratic Legitimacy: The Case of Gaza Settlers," Communication Research, 32 (6), 794-821.
   Google Scholar
• U.S. Food and Drug Administration (FDA) (2004a), "Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs: Summary of FDA Survey Research Results," Final Report (November 19), available at www.fda.gov/cdr/ddmac/Final%20Report/FRfinal1111904.pdf
   Google Scholar
• U.S. Food and Drug Administration (FDA) (2004b), "FDA News: New FDA Draft Guidances Aim to Improve Health Information," press release (February 4), available at www.fda.gov/bbs/topics/news/2004/new01016.html
   Google Scholar
• U.S. Food and Drug Administration (FDA) (2004c), "Guidance for Industry Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements [Draft Guidance]," available at www.fda.gov/cder/guidance/5669dft.pdf
   Google Scholar
• U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) (1999), Attitudes and Behaviors Associated with Direct-to-Consumer Promotion of Prescription Drugs, available at www.fda.gov/cder/ddmac/research.htm
   Google Scholar
• Vecchio, Anthony (1997), "Direct Concerns: Pharmacists Wary of Surge in Consumer Rx Drug Ads," Drug Topics (July 21), available at www.drugtopics.com
   Google Scholar
• Viale, Pamela H., and Deanna S. Yamamoto (2004), "The Attitudes and Beliefs of Oncology Nurse Practitioners Regarding Direct-to-Consumer Advertising of Prescription Medications," Oncology Nursing Forum, 31 (4), 777-784.
   Google Scholar
• Weissman, Joel S., David Blumenthal, Alvin J. Silk, Michael Newman, Kinga Zapert, Robert Leitman, and Sandra Felbelmann (2004), "Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising," Health Affairs, 23 (3), W4219-4233.
   Google Scholar
• Wilkes, Michael S., Robert A. Bell, and Richard L. Kravitz (2000), "Direct-to-Consumer Prescription Drug Advertising: Trends, Impact, and Implications," Health Affairs, 19 (2), 110-128.
   Google Scholar
• Woodcock, Janet (2001), Statement of Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Department of Health and Human Services, Before the Subcommittee on Health, House Committee on Energy and Commerce, for the Hearing on "Recent Developments Which May Impact Consumer Access to, and Demand for, Pharmaceuticals" (June 13), available at www.fda.gov/ola/2001/cderwork0613.html
   Google Scholar
• Woodcock, Janet (2003), Statement of Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Department of Health and Human Services, Before the Senate Special Committee on Aging (July 22), available at www.fda.gov/ola/2003/AdvertisingofPrescriptionDrugs0722.html
   Google Scholar
• Youn, Seounmi, Ronald J. Faber, and Dhavan V. Shah (2000), "Restricting Gambling Advertising and the Third-Person Effect," Psychology and Marketing, 17 (7), 633-649.
   Google Scholar
• Yuan, Yilian, and Nancy Duckwitz (2002), "Doctors and DTC," Pharmaceutical Executive (August), 1-7.
   Google Scholar
• Zachry, Woodie M., James E. Dalen, and Terrence R. Jackson (2003), "Clinicians Responses to Direct-to-Consumer Advertising of Prescription Medications," Archives of Internal Medicine, 163 (15), 1808-1812.
   Google Scholar